Skip to main content
Search
Search This Blog
Biopharma Over Coffee
Updates on recent goings on in the pharma, biotech and healthcare sectors.
Posts
Showing posts from 2026
Show all
September 22, 2026
ENHERTU and the changing economics of access to innovation in the NHS in England
July 10, 2026
EU Joint Clinical Assessment after the first reports: How should companies interpret the findings?
May 28, 2026
England’s Single National Formulary: Win-Win Reform or New Market Access Bottleneck?
April 24, 2026
Anti-Amyloid Drugs in Alzheimer’s: Breakthrough, Dead End, or Reimbursement Reality Check?
February 12, 2026
MFN Pricing and the “Global Launch Freeze”: A More Measured Perspective
Newer Posts
Older Posts
Home
